Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TNFSF9 Stable Cell Line

    [CAT#: S01YF-1023-PY244]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Oncology Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Oncology
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;Huh-7;SMMC-7721
    Target Classification
    Oncology Cell Lines
    Target Research Area
    Cancer Research;Immunology Research
    Related Diseases
    Immunodeficiency 16; Mouth Disease
    Gene ID
    Human:8744
    UniProt ID
    Human:P41273

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    TNFSF9, also known as 4-1BBL, has been investigated in various cancer types, including osteosarcoma, hepatoblastoma, hepatocellular carcinoma (HCC), and glioblastoma multiforme (GBM). In osteosarcoma, high expression of TNFSF9 is associated with poor prognosis, while low expression is correlated with an abundance of CD4+ memory-activated T cells. In hepatoblastoma, extracellular calcium ions promote cell proliferation and migration, as well as decrease sensitivity to cisplatin, through the upregulation of TNFSF9. In HCC, TNFSF9 is involved in the resistance to Lenvatinib plus anti-PD1 antibodies treatment, and its expression is associated with immune cell infiltration. In GBM, TNFSF9 is highly expressed in microglia and is identified as a potential target in the tumor microenvironment. These studies highlight the diverse roles of TNFSF9 in cancer progression and its potential as a prognostic biomarker and therapeutic target in different cancer types.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human TNFSF9 Stable Cell Line (S01YF-1023-PY244). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Cameron Davis (Verified Customer)

    What is the therapeutic potential of TNFSF9 in cancer? Jan 05 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    TNFSF9 is being explored for its role in antitumor immunotherapy, particularly in enhancing T-cell responses against tumors. Jan 05 2023

    chat Jordan Smith (Verified Customer)

    How does TNFSF9 contribute to cancer metastasis? Apr 26 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    TNFSF9 has been found to promote metastasis in cancers like pancreatic cancer, indicating its role in tumor progression. Apr 26 2023

    Published Data

    Fig.1 In vitro, the proliferation of HCC cells is hindered by TNFSF9.

    The expression of TNFSF9 in Huh7 and SMMC-7721 HCC cells was analyzed by Western blot, with TNFSF9 being stably transfected and controls (empty vector) used. The determination of cell proliferation in TNFSF9-overexpressing Huh7 and SMMC-7721 cells and control cells was accomplished through the MTS assay, with the absorbance at 490 nm serving as the measure of the results.

    Ref: Shen, Yu Ling, et al. "TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma." Journal of digestive diseases 18.7 (2017): 395-403.

    Pubmed: 28547807

    DOI: 10.1111/1751-2980.12489

    Research Highlights

    Xie, Long. et al. "RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma." PloS one, 2023.
    Receptor activity modifying protein 1 (RAMP1) plays a crucial role in facilitating the localization of calcitonin-like receptor (CLR) to the plasma membrane. However, its role in osteosarcoma (OS) remains unclear. A recent study evaluated the expression of RAMP1 and its prognostic value across various cancers, with a particular focus on tumor immune infiltration. This analysis utilized the GSE39058 and TARGET datasets and found that high RAMP1 expression was associated with poor prognosis in OS patients (p<0.05). Additionally, differential gene expression and protein-protein interaction networks were analyzed, and gene set enrichment analysis was performed. These findings suggested that RAMP1 may play a critical role in the tumor microenvironment, as its expression was also validated in OS cell lines using quantitative real-time PCR. Notably, low RAMP1 expression was linked to an abundance of CD4+ memory-activated T cells, while high expression correlated with a high proportion of gamma-delta T cells. Furthermore, differential gene expression analysis from the TARGET dataset revealed an enrichment of olfactory transduction pathways (normalized enrichment scores [NES] = 1.6998, p < 0.0001). Interestingly, RAMP1 expression was also found to be negatively correlated with CD44 expression but positively correlated with TNFSF9 expression. Further analysis showed significantly higher RAMP1 gene expression in OS cells compared to a normal osteoblast cell line, hFOB1.19. These findings suggest that RAMP1 may serve as a prognostic biomarker and potential therapeutic target in OS.
    Xie, Long. et al. "RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma." PloS one, 2023.
    Pubmed: 37796823   DOI: 10.1371/journal.pone.0292452

    Xu, Haozhe. et al. "Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity." Journal of biomedical research, 2023.
    Hepatoblastoma, the most common type of liver cancer in children, has been the focus of numerous studies. In one particular study, a team of researchers observed that the addition of calcium ions to the culturing medium of HepG2, a cell line derived from hepatoblastoma, resulted in a reduction of cell clumping. Further investigations revealed that this calcium signal plays a crucial role in the development of tumors. The team's findings suggest that calcium ions induce morphological changes and promote cell proliferation and migration through the activation of FAK, protein kinase B, and p38 mitogen-activated protein kinase signaling pathways.
    Xu, Haozhe. et al. "Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity." Journal of biomedical research, 2023.
    Pubmed: 37750331   DOI: 10.7555/JBR.37.20230067

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare